Islet Transplantation for Brittle Type 1 Diabetes: The UIC Protocol
Open Access
- 30 May 2008
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 8 (6) , 1250-1261
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL‐2 receptor blockade in an islet transplant recipientClinical Transplantation, 2007
- Effect of Exenatide on ?? Cell Function After Islet Transplantation in Type 1 DiabetesTransplantation, 2007
- International Trial of the Edmonton Protocol for Islet TransplantationNew England Journal of Medicine, 2006
- Exenatide Improves Glycemic Control and Reduces Body Weight in Subjects with Type 2 Diabetes: A Dose-Ranging StudyDiabetes Technology & Therapeutics, 2005
- Single-Donor, Marginal-Dose Islet Transplantation in Patients With Type 1 DiabetesJAMA, 2005
- Assessment of the Severity of Hypoglycemia and Glycemic Lability in Type 1 Diabetic Subjects Undergoing Islet TransplantationDiabetes, 2004
- Consequences on β-Cell Function and Reserve After Long-Term Pancreas TransplantationDiabetes, 2004
- Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes*Diabetologia, 2002
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998